tetano
Editor, Senior Moderator
J Med Virol
. 2023 Dec;95(12):e29286.
doi: 10.1002/jmv.29286. Differential effects of microRNAs miR-21, miR-99 and miR-145 on lung regeneration and inflammation during recovery from influenza pneumonia
Joe Wee Jian Ong[SUP] 1 [/SUP], Kai Sen Tan[SUP] 1 [/SUP], Joseph Jing Xian Lee[SUP] 2 [/SUP], Ju Ee Seet[SUP] 3 [/SUP], Hyung Won Choi[SUP] 2 [/SUP], Siok Ghee Ler[SUP] 4 [/SUP], Jayantha Gunaratne[SUP] 4 [/SUP], Teluguakula Narasaraju[SUP] 5 [/SUP], Lok-To Sham[SUP] 1 [/SUP], Volker Patzel[SUP] 1 6 [/SUP], Vincent T Chow[SUP] 1 [/SUP]
Affiliations
In a mouse model of influenza pneumonia, we previously documented that proliferating alveolar type II (AT2) cells are the major stem cells involved in early lung recovery. Profiling of microRNAs revealed significant dysregulation of specific ones, including miR-21 and miR-99a. Moreover, miR-145 is known to exhibit antagonism to miR-21. This follow-up study investigated the roles of microRNAs miR-21, miR-99a, and miR-145 in the murine pulmonary regenerative process and inflammation during influenza pneumonia. Inhibition of miR-21 resulted in severe morbidity, and in significantly decreased proliferating AT2 cells due to impaired transition from innate to adaptive immune responses. Knockdown of miR-99a culminated in moderate morbidity, with a significant increase in proliferating AT2 cells that may be linked to PTEN downregulation. In contrast, miR-145 antagonism did not impact morbidity nor the proliferating AT2 cell population, and was associated with downregulation of TNF-alpha, IL1-beta, YM1, and LY6G. Hence, a complex interplay exists between expression of specific miRNAs, lung regeneration, and inflammation during recovery from influenza pneumonia. Inhibition of miR-21 and miR-99a (but not miR-145) can lead to deleterious cellular and molecular effects on pulmonary repair and inflammatory processes during influenza pneumonia.
Keywords: RNA sequencing; influenza; lung regeneration; miR-145; miR-21; miR-99a; microRNAs; pneumonia; proliferating AT2 cells; stem cells.
. 2023 Dec;95(12):e29286.
doi: 10.1002/jmv.29286. Differential effects of microRNAs miR-21, miR-99 and miR-145 on lung regeneration and inflammation during recovery from influenza pneumonia
Joe Wee Jian Ong[SUP] 1 [/SUP], Kai Sen Tan[SUP] 1 [/SUP], Joseph Jing Xian Lee[SUP] 2 [/SUP], Ju Ee Seet[SUP] 3 [/SUP], Hyung Won Choi[SUP] 2 [/SUP], Siok Ghee Ler[SUP] 4 [/SUP], Jayantha Gunaratne[SUP] 4 [/SUP], Teluguakula Narasaraju[SUP] 5 [/SUP], Lok-To Sham[SUP] 1 [/SUP], Volker Patzel[SUP] 1 6 [/SUP], Vincent T Chow[SUP] 1 [/SUP]
Affiliations
- PMID: 38087452
- DOI: 10.1002/jmv.29286
In a mouse model of influenza pneumonia, we previously documented that proliferating alveolar type II (AT2) cells are the major stem cells involved in early lung recovery. Profiling of microRNAs revealed significant dysregulation of specific ones, including miR-21 and miR-99a. Moreover, miR-145 is known to exhibit antagonism to miR-21. This follow-up study investigated the roles of microRNAs miR-21, miR-99a, and miR-145 in the murine pulmonary regenerative process and inflammation during influenza pneumonia. Inhibition of miR-21 resulted in severe morbidity, and in significantly decreased proliferating AT2 cells due to impaired transition from innate to adaptive immune responses. Knockdown of miR-99a culminated in moderate morbidity, with a significant increase in proliferating AT2 cells that may be linked to PTEN downregulation. In contrast, miR-145 antagonism did not impact morbidity nor the proliferating AT2 cell population, and was associated with downregulation of TNF-alpha, IL1-beta, YM1, and LY6G. Hence, a complex interplay exists between expression of specific miRNAs, lung regeneration, and inflammation during recovery from influenza pneumonia. Inhibition of miR-21 and miR-99a (but not miR-145) can lead to deleterious cellular and molecular effects on pulmonary repair and inflammatory processes during influenza pneumonia.
Keywords: RNA sequencing; influenza; lung regeneration; miR-145; miR-21; miR-99a; microRNAs; pneumonia; proliferating AT2 cells; stem cells.